Jun 22, 2020 07:00AM
May 18, 2020 08:30AM
May 18, 2020 08:30AM
May 7, 2020 07:30AM
May 7, 2020 07:30AM
Apr 14, 2020 09:00AM
Mar 13, 2020 08:30AM PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS
Mar 13, 2020 08:30AM
Feb 20, 2020 11:30AM
Jan 21, 2020 04:24PM
Jan 21, 2020 04:15PM
Jan 21, 2020 04:15PM
Dec 23, 2019 08:44AM
Dec 23, 2019 07:01AM Progenics Pharma (PGNX) Phase 3 CONDOR Trial of PyL in Prostate Cancer Achieved Primary Endpoint
Dec 23, 2019 07:00AM
Dec 23, 2019 07:00AM
Nov 7, 2019 08:00AM
Nov 7, 2019 08:00AM
Oct 23, 2019 05:03PM
Oct 21, 2019 08:00AM
Oct 2, 2019 09:19AM Pre-Open Movers 10/02: (VHC) (AIMT) (LEN) Higher; (SVRA) (UNFI) (AYI) Lower (more...)
Oct 2, 2019 07:09AM
Oct 2, 2019 07:08AM
Aug 12, 2019 08:00AM
Aug 9, 2019 07:30AM
Aug 6, 2019 08:39AM
Aug 6, 2019 08:30AM
Aug 6, 2019 08:30AM CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRA® (iobenguane I 131)
Aug 5, 2019 08:37AM
Aug 5, 2019 08:30AM
Aug 5, 2019 08:30AM
Jul 17, 2019 07:41PM
Jun 20, 2019 08:36AM
Jun 20, 2019 08:30AM
Jun 20, 2019 08:30AM Progenics Pharmaceuticals to Initiate a Basket Trial by Year End to Support an Expanded Label for AZEDRA® (iobenguane I 131) in Multiple MIBG Avid Neuroendocrine Tumors
Jun 20, 2019 07:30AM
Jun 19, 2019 08:30AM
Jun 19, 2019 08:30AM
Jun 17, 2019 08:30AM
Jun 13, 2019 05:00PM
Jun 13, 2019 05:00PM
Jun 13, 2019 08:31AM Progenics Pharma (PGNX) Reports First Patient Dosing in Phase 2 Clinical Study of 1095 Radiotherapy for the Treatment of Metastatic Prostate Cancer
Jun 13, 2019 08:30AM
Jun 13, 2019 08:30AM
Jun 4, 2019 08:30AM
Jun 3, 2019 08:34AM
Jun 3, 2019 08:30AM
Jun 3, 2019 08:30AM
Jun 3, 2019 08:00AM Progenics Pharmaceuticals Mails Letter to Shareholders
Jun 3, 2019 08:00AM

324,023 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All